2025 Hyundai Elantra Limited
Stock #: 46705
Lease for $249 per month, plus tax, 36 months $2,999 Due at Lease Signing
*1 at this payment.VIN: KMHLP4DG5SU065960 Stock #: 46705 Model Code: 494J2F4S net Capitalized Cost $22,434.33. $249 plus tax monthly for 36 months with $2,997 Due at lease Signing. payment includes $750 HMF Lease Cash.$85 Dealer Document Preparation Charges, any Electronic Filing Fee. $0.20 per mile over 10,000 miles per year.Security Deposit Not Required. On Approved Above Average Credit through hyundai motors finance. Vehicle shown for illustrative purposes only. Offer expires 2/02/2026.
2025 Hyundai Elantra Limited
Fill out this form to take advantage of this great offer.
*Although every reasonable effort has been made to ensure the accuracy of the information contained on this site, absolute accuracy cannot be guaranteed. This site, and all information and materials appearing on it, are presented to the user "as is" without warranty of any kind, either express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, title or non-infringement. All vehicles are subject to prior sale. Prices exclude government fees and taxes, any finance charges, $85 dealer documentation preparation charge, any electronic filing charge, any emissions testing charges and any optional equipment. Dalton Hyundai installs alarm systems on their vehicles to protect them while on dealer's premises. The advertised prices do not include the purchase of the alarm system. The anti-theft device can be purchased for an additional cost. Purchase of the anti-theft device is not required. If customer does not purchase the alarm system it will be removed prior to delivery. All advertised prices expire daily at midnight.
More Info
Compare Certified Programs
|
|
|
|
|---|---|---|
| Vehicle eligibility | 6 model years old and newer with 80k miles or less |
|
| Vehicle inspection | 173-point inspection | 117-point inspection |
| Limited warranties |
|
|
| If anything happens |
|
|
| Complimentary trials |
|
|